ATE230272T1 - Haiknorpel extrakte,verfahren zur herstellung und verwendungen desselben - Google Patents

Haiknorpel extrakte,verfahren zur herstellung und verwendungen desselben

Info

Publication number: ATE230272T1
Authority: AT; Austria
Prior art keywords: extract; cartilage; cartilage extracts; homogenate; extracts
Prior art date: 1995-02-03

Application number

AT95935309T

Other languages

English (en)

Inventor

Eric Dupont

Paul Brazeau

Christina Juneau

Daniel H Maes

Kenneth Marenus

Original Assignee

Lab Aeterna Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1995-02-03

Filing date

1995-10-30

Publication date

2003-01-15

1995-02-03 Priority claimed from US08/384,555 external-priority patent/US5618925A/en

1995-10-30 Application filed by Lab Aeterna Inc filed Critical Lab Aeterna Inc

2003-01-15 Application granted granted Critical

2003-01-15 Publication of ATE230272T1 publication Critical patent/ATE230272T1/de

Links

239000000284 extract Substances 0.000 title abstract 9
238000000034 method Methods 0.000 title abstract 7
210000000845 cartilage Anatomy 0.000 title abstract 5
241000251730 Chondrichthyes Species 0.000 title abstract 2
239000007788 liquid Substances 0.000 abstract 2
206010061218 Inflammation Diseases 0.000 abstract 1
206010028980 Neoplasm Diseases 0.000 abstract 1
230000033115 angiogenesis Effects 0.000 abstract 1
230000001772 anti-angiogenic effect Effects 0.000 abstract 1
230000000791 anti-collagenolytic effect Effects 0.000 abstract 1
230000003110 anti-inflammatory effect Effects 0.000 abstract 1
230000000259 anti-tumor effect Effects 0.000 abstract 1
239000007864 aqueous solution Substances 0.000 abstract 1
230000004071 biological effect Effects 0.000 abstract 1
238000012512 characterization method Methods 0.000 abstract 1
201000010099 disease Diseases 0.000 abstract 1
208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
230000000694 effects Effects 0.000 abstract 1
238000005194 fractionation Methods 0.000 abstract 1
230000004054 inflammatory process Effects 0.000 abstract 1
239000000203 mixture Substances 0.000 abstract 1
230000002062 proliferating effect Effects 0.000 abstract 1
230000035755 proliferation Effects 0.000 abstract 1
229940007115 shark cartilage extract Drugs 0.000 abstract 1
230000001225 therapeutic effect Effects 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/98—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution of animal origin
- A61K8/987—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution of animal origin of species other than mammals or birds
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/30—Zinc; Compounds thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/60—Fish, e.g. seahorses; Fish eggs
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/02—Peptides of undefined number of amino acids; Derivatives thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/10—Anti-acne agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/16—Emollients or protectives, e.g. against radiation
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/18—Antioxidants, e.g. antiradicals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/08—Anti-ageing preparations

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Chemical & Material Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Dermatology (AREA)
Epidemiology (AREA)
Diabetes (AREA)
Ophthalmology & Optometry (AREA)
Inorganic Chemistry (AREA)
Rheumatology (AREA)
Hematology (AREA)
Toxicology (AREA)
Immunology (AREA)
Vascular Medicine (AREA)
Cardiology (AREA)
Heart & Thoracic Surgery (AREA)
Communicable Diseases (AREA)
Birds (AREA)
Oncology (AREA)
Obesity (AREA)
Biochemistry (AREA)
Endocrinology (AREA)
Orthopedic Medicine & Surgery (AREA)
Physical Education & Sports Medicine (AREA)
Marine Sciences & Fisheries (AREA)
Emergency Medicine (AREA)
Urology & Nephrology (AREA)
Gerontology & Geriatric Medicine (AREA)
Zoology (AREA)

AT95935309T 1995-02-03 1995-10-30 Haiknorpel extrakte,verfahren zur herstellung und verwendungen desselben ATE230272T1 (de)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US08/384,555 US5618925A (en)	1994-04-28	1995-02-03	Extracts of shark cartilage having an anti-angiogenic activity and an effect on tumor regression; process of making thereof
PCT/CA1995/000617 WO1996023512A1 (en)	1995-02-03	1995-10-30	Extracts of shark cartilage, process of production and uses thereof

Publications (1)

Publication Number	Publication Date
ATE230272T1 true ATE230272T1 (de)	2003-01-15

Family

ID=23517788

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT95935309T ATE230272T1 (de)	1995-02-03	1995-10-30	Haiknorpel extrakte,verfahren zur herstellung und verwendungen desselben

Country Status (23)

Country	Link
EP (1)	EP0806960B1 (de)
JP (3)	JPH11502514A (de)
KR (1)	KR100347880B1 (de)
CN (1)	CN1138550C (de)
AT (1)	ATE230272T1 (de)
AU (1)	AU717978B2 (de)
BG (1)	BG63801B1 (de)
BR (1)	BR9510540A (de)
CA (1)	CA2212010C (de)
CZ (1)	CZ292627B6 (de)
DE (1)	DE69529300T2 (de)
DK (1)	DK0806960T3 (de)
ES (1)	ES2188672T3 (de)
FI (1)	FI117376B (de)
HU (1)	HU222088B1 (de)
IS (1)	IS1963B (de)
MX (1)	MX9705894A (de)
NO (1)	NO318950B1 (de)
NZ (1)	NZ294553A (de)
PL (1)	PL188137B1 (de)
RO (1)	RO117590B1 (de)
RU (1)	RU2157695C2 (de)
WO (1)	WO1996023512A1 (de)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6025334A (en) *	1994-04-28	2000-02-15	Les Laboratoires Aeterna Inc.	Extracts of shark cartilage having anti-collagenolytic, anti-inflammatory, anti-angiogenic and anti-tumoral activities; process of making, methods of using and compositions thereof
US6380366B1 (en)	1994-04-28	2002-04-30	Les Laboratoires Aeterna Inc.	Shark cartilage extract:process of making, methods of using and compositions thereof
AU724654B2 (en) *	1995-04-21	2000-09-28	Aeterna Zentaris Inc.	Extracts of shark cartilage
WO1998036760A1 (en)	1997-02-20	1998-08-27	Industrial Research Limited	Angiogenesis inhibitors and activators from shark cartilage
CA2281570C (en) *	1997-03-11	2003-09-23	Les Laboratoires Aeterna Inc.	Composition for treating tumors containing shark cartilage extracts and anti-neoplastic agents
CA2295519C (en) *	1997-07-11	2008-12-16	Cv Technologies Inc.	A preparation derived from shark cartilage for treatment of diseases related to excessive phf or excessive intracellular calcium
AUPO920597A0 (en) *	1997-09-16	1997-10-09	Micronized Foods Pty Ltd	Pharmaceutical and/or therapeutic composition or preparation comprising shark cartilage and emu oil
US6168807B1 (en)	1998-07-23	2001-01-02	Les Laboratoires Aeterna Inc.	Low molecular weight components of shark cartilage, processes for their preparation and therapeutic uses thereof
US20020009501A1 (en) *	1998-07-23	2002-01-24	Eric Dupont	Preparation of cartilage extracts using organic solvents
CN1064690C (zh) *	1998-09-10	2001-04-18	中国人民解放军海军医学研究所	鲨鱼软骨血管生成抑制因子及其分离纯化方法
RU2161002C1 (ru) *	1999-07-30	2000-12-27	Государственное унитарное предприятие Тихоокеанский научно-исследовательский рыбохозяйственный центр	Пищевой общеукрепляющий лечебно-профилактический продукт из хрящевой ткани акул и способ его получения
US6248341B1 (en) *	2000-01-14	2001-06-19	Color Access, Inc.	Method of treating topical angiogenesis-related disorders
BR0017224A (pt) *	2000-04-18	2003-01-07	Ceteris Holding B V Amsterdam	Composição baseada em extratos naturais útil na prevenção e tratamento de rugas cutaneas
CA2423331A1 (en) *	2000-12-20	2002-06-27	Industrial Research Limited	Shark meat extract
US20070010430A1 (en) *	2003-03-20	2007-01-11	Hosokawa Micron Corparation	Proteoglycan isolated from cartilaginous fish and process for producing the same
ES2223291B1 (es) *	2003-08-06	2006-03-16	Bioiberica, S.A.	Nuevo uso terapeutico de condroitin sulfato.
US7205006B2 (en) *	2003-09-25	2007-04-17	Prime Pharmaceutical Corporation	Mahonia aquifolium extract, extraction process and pharmaceutical composition containing the same
CN100377741C (zh) *	2004-02-23	2008-04-02	江卫世	注射用复方骨肽及其制备工艺
RU2250774C1 (ru) *	2004-04-29	2005-04-27	Научно-исследовательский институт медико-биологических проблем Владикавказского научного центра РАН и Правительства РСО-Алания (НИИ МБП ВНЦ РАН)	Способ оптимизации лечения хронического простатита
US20070248930A1 (en)	2005-02-17	2007-10-25	Biolux Research Ltd.	Light therapy apparatus and methods
WO2012048423A1 (en)	2010-10-13	2012-04-19	Biolux Research Limited	Method and apparatus for tooth regulation with heavy forces
WO2012075584A1 (en)	2010-12-08	2012-06-14	Biolux Research Limited	Methods and apparatuses useful for regulating bone remodeling or tooth movement using light therapy, a functional appliance, and/or vitamin d
RU2600166C2 (ru) *	2011-12-04	2016-10-20	Дэвид Л. ЛЬЮ	Лекарственное средство, содержащее ионы натрия и ионы кальция, для лечения рака, опухоли и незлокачественной гиперплазии
RU2489906C1 (ru) *	2012-04-18	2013-08-20	Тамара Ивановна Николаева	Биологически активная добавка к пище на основе денатурированного коллагена
US20130280671A1 (en)	2012-04-19	2013-10-24	Biolux Research Ltd.	Intra-oral light therapy apparatuses and methods for their use
US20130287859A1 (en) *	2012-04-26	2013-10-31	Lescarden Inc.	Method for treating prupritus with cartilage extract
DE102012023927A1 (de) *	2012-12-06	2014-06-12	Heinrich Huber	Heilsalbe gegen Psoriasis, auch als Wundsalbe verwendbar; 50 ml ohne Konservierung
DE202014011570U1 (de)	2013-10-22	2023-04-04	Biolux Research Holdings, Inc.	Intraorale Lichttherapiegeräte
CN106492065A (zh) *	2016-10-20	2017-03-15	王凯茜	一种治疗风湿热的中药
KR102369902B1 (ko) *	2021-04-23	2022-03-02	이수한	전 처리된 캐비아가 함유된 철갑상어 진액 및 그 제조 방법

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4822607A (en) *	1976-10-29	1989-04-18	Lescarden Ltd.	Anti-tumor agent and method
US4473551A (en) *	1982-08-23	1984-09-25	Faxon Pharmaceuticals, Inc.	Anti-inflammatory composition
US4486414A (en) *	1983-03-21	1984-12-04	Arizona Board Of Reagents	Dolastatins A and B cell growth inhibitory substances
US5075112A (en) *	1990-02-12	1991-12-24	Cartilage Technologies Inc.	Method of and dosage unit for inhibiting angiogenesis or vascularization in an animal using shark cartilage
IT1244879B (it) *	1990-12-11	1994-09-12	Alberto Bartorelli	Estratti da tessuti animali, utili in terapia e in diagnostica.
RU2019173C1 (ru) *	1993-01-12	1994-09-15	Яков Давидович Безман	Способ лечения подкожной фибросаркомы
RU2019180C1 (ru) *	1993-01-12	1994-09-15	Яков Давидович Безман	Средство для лечения подкожной фибросаркомы и способ его получения
US5618925A (en) *	1994-04-28	1997-04-08	Les Laboratories Aeterna Inc.	Extracts of shark cartilage having an anti-angiogenic activity and an effect on tumor regression; process of making thereof

1995
- 1995-10-30 RO RO97-01452A patent/RO117590B1/ro unknown
- 1995-10-30 AU AU37388/95A patent/AU717978B2/en not_active Ceased
- 1995-10-30 JP JP8523128A patent/JPH11502514A/ja active Pending
- 1995-10-30 WO PCT/CA1995/000617 patent/WO1996023512A1/en not_active Ceased
- 1995-10-30 DE DE69529300T patent/DE69529300T2/de not_active Expired - Fee Related
- 1995-10-30 AT AT95935309T patent/ATE230272T1/de not_active IP Right Cessation
- 1995-10-30 NZ NZ294553A patent/NZ294553A/xx unknown
- 1995-10-30 KR KR1019970705335A patent/KR100347880B1/ko not_active Expired - Fee Related
- 1995-10-30 BR BR9510540A patent/BR9510540A/pt not_active Application Discontinuation
- 1995-10-30 PL PL95321678A patent/PL188137B1/pl not_active IP Right Cessation
- 1995-10-30 DK DK95935309T patent/DK0806960T3/da active
- 1995-10-30 ES ES95935309T patent/ES2188672T3/es not_active Expired - Lifetime
- 1995-10-30 CZ CZ19972452A patent/CZ292627B6/cs not_active IP Right Cessation
- 1995-10-30 CA CA002212010A patent/CA2212010C/en not_active Expired - Fee Related
- 1995-10-30 CN CNB951977598A patent/CN1138550C/zh not_active Expired - Fee Related
- 1995-10-30 RU RU97114752/14A patent/RU2157695C2/ru not_active IP Right Cessation
- 1995-10-30 HU HU9800065A patent/HU222088B1/hu not_active IP Right Cessation
- 1995-10-30 EP EP95935309A patent/EP0806960B1/de not_active Expired - Lifetime
1997
- 1997-08-01 NO NO19973564A patent/NO318950B1/no unknown
- 1997-08-01 MX MX9705894A patent/MX9705894A/es not_active IP Right Cessation
- 1997-08-01 IS IS4537A patent/IS1963B/is unknown
- 1997-08-01 FI FI973195A patent/FI117376B/fi not_active IP Right Cessation
- 1997-09-01 BG BG101870A patent/BG63801B1/bg unknown
2003
- 2003-02-05 JP JP2003028771A patent/JP2003246742A/ja active Pending
2006
- 2006-07-31 JP JP2006208897A patent/JP2006290904A/ja active Pending

Also Published As

Publication number	Publication date
CZ292627B6 (cs)	2003-11-12
RO117590B1 (ro)	2002-05-30
NO318950B1 (no)	2005-05-30
JP2006290904A (ja)	2006-10-26
EP0806960A1 (de)	1997-11-19
ES2188672T3 (es)	2003-07-01
PL188137B1 (pl)	2004-12-31
EP0806960B1 (de)	2003-01-02
FI973195A0 (fi)	1997-08-01
CA2212010A1 (en)	1996-08-08
IS4537A (is)	1997-08-01
CZ245297A3 (cs)	1998-01-14
FI973195L (fi)	1997-10-01
NO973564D0 (no)	1997-08-01
BG63801B1 (bg)	2003-01-31
HUT77488A (hu)	1998-05-28
NO973564L (no)	1997-10-01
HU222088B1 (hu)	2003-04-28
CN1138550C (zh)	2004-02-18
DK0806960T3 (da)	2003-04-22
NZ294553A (en)	1999-07-29
KR100347880B1 (ko)	2002-12-02
RU2157695C2 (ru)	2000-10-20
MX9705894A (es)	1998-07-31
BG101870A (en)	1998-04-30
AU717978B2 (en)	2000-04-06
WO1996023512A1 (en)	1996-08-08
JPH11502514A (ja)	1999-03-02
AU3738895A (en)	1996-08-21
IS1963B (is)	2004-12-15
BR9510540A (pt)	1998-06-09
CN1177927A (zh)	1998-04-01
CA2212010C (en)	2004-08-17
FI117376B (fi)	2006-09-29
JP2003246742A (ja)	2003-09-02
DE69529300D1 (de)	2003-02-06
PL321678A1 (en)	1997-12-22
DE69529300T2 (de)	2003-07-03

Legal Events

Date

Code

Title

Description

2003-04-15

UEP

Publication of translation of european patent specification

Ref document number: 0806960

Country of ref document: EP

2005-09-15

EEFA

Change of the company name

2008-07-15

REN

Ceased due to non-payment of the annual fee

Publication	Publication Date	Title
DE69529300D1 (de)	2003-02-06	Haiknorpel extrakte,verfahren zur herstellung und verwendungen desselben
NO981781D0 (no)	1998-04-21	Ekstrakter av haibrusk
DE69528258D1 (de)	2002-10-24	Haiknorpelextrakte mit antiangiogenischer wirkung und einem effekt auf tumorregression und verfahren zur herstellung derselben
DE59000270D1 (de)	1992-10-01	Verwendung von mindestens ein cytokin zur herstellung eines arzneimittels zur systemischen behandlung von praeneoplastischen laesionen.
RU96123763A (ru)	1999-02-20	Экстракты акульего хряща, обладающие антиангиогенной активностью и оказывающие влияние на регрессию опухоли; способы их получения
DE69121502D1 (de)	1996-09-26	Prozess zur darstellung von aspartam aus einem diketopiperazin sowie neue zwischenprodukte und derivate dafür
ATE311871T1 (de)	2005-12-15	Verwendung von zinksalzen der konjugierten linoleinsäuren zur behandlung von hautkrankheiten
DE69130679D1 (de)	1999-02-04	Die herstellung von zusammensetzungen zur behandlung von krankheiten der zellproliferation
ATE151774T1 (de)	1997-05-15	Cyclopentanperhydrophenanthren-17-beta-(3-furyl - 3-derivate und pharmazeutische präparate davon, zur behandlung von kardiovaskulär-erkrankungen
DE2447050C2 (de)	1983-07-28	Verfahren zur Gewinnung von Proteasenhemmstoff
ATE249755T1 (de)	2003-10-15	Verfahren zur herstellung von funktionellen bestandteilen aus wachsartigem maismehl, danach hergestellte produkte und ihre verwendungen
DE68922013D1 (de)	1995-05-11	Verfahren zur Herstellung von rektifiziertem Vetiverol und Vetiveröl, und diese enthaltende Parfümeriezusammensetzungen.
WO1992000678A3 (fr)	1992-04-02	Procede de bioconversion de matieres grasses, notamment pour l'obtention de concentres d'aromes
DE69717961D1 (de)	2003-01-30	Verwendung eines flavonoid enthaltenden extraktes der planze euphorbia prostrata zur herstellung eines medikamentes zur behandlung von anoraktalen oder kolonbeschwerden
KR960013217A (ko)	1996-05-22	알리신을 함유하는 가공치즈 및 그의 제조 방법
DE58902887D1 (de)	1993-01-14	Verfahren zur herstellung von symmetrischen und unsymmetrischen monoacetalen aromatischer 1,2-diketone.
ATE192336T1 (de)	2000-05-15	Verwendung von bifemelan zur herstellung eines arzneimittels zur behandlung der hyperkinesie